On the evening of Sunday 13th September during the European Society of Cataract and Refractive Surgeons (ESCRS), delegates gathered for an insightful educational symposium, ‘Ciclosporin Unleashed: A New Era of Innovation’, exploring how advances in ciclosporin therapy are helping clinicians deliver treatment without compromise for patients with ocular surface disease.
Chaired by Ms Bita Manzouri, the meeting featured expert presentations from Mr Jeremy Hoffman, Mr Ankur Barua, and Prof Sathish Srinivasan, who shared their perspectives on the evolution of ciclosporin, the importance of making confident treatment decisions, and the application of clinical evidence in everyday practice.
The symposium opened with a review of the evolution of ciclosporin therapy, highlighting how innovation has expanded treatment options and helped address longstanding challenges in the management of dry eye disease. Faculty members discussed the growing body of evidence supporting ciclosporin and how advances in formulation are contributing to improved patient care.
A central theme throughout the evening was the concept of treatment without compromise. Speakers emphasised the importance of getting treatment right first time, ensuring patients receive effective therapy before disease progression, ongoing symptoms, or treatment dissatisfaction have the potential to impact outcomes. By selecting appropriate therapies at the appropriate opportunity, clinicians can help optimise both clinical results and the overall patient experience.
Bringing these principles to life, Prof Sathish Srinivasan shared a series of real-world clinical cases demonstrating the impact of innovative ciclosporin therapy in UK patients. The cases highlighted the challenges faced in practice and illustrated how personalised treatment decisions can support improved disease control, patient satisfaction, and long-term management success.
The symposium had a clear message: innovation in ciclosporin therapy is enabling ophthalmologists to move beyond treatment trade-offs and deliver care with greater confidence.
FURTHER INFORMATION:
